Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Research progress on the anticarcinogenic actions and mechanisms of ellagic acid

Hong-Mei Zhang, Lei Zhao, Hao Li, Hao Xu, Wen-Wen Chen and Lin Tao
Cancer Biology & Medicine June 2014, 11 (2) 92-100; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.02.004
Hong-Mei Zhang
1Medical Sciences Research Center, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhmnj2008{at}aliyun.com
Lei Zhao
1Medical Sciences Research Center, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Li
2Department of Pharmacy, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Xu
3Nanjing Longyuan Natural Polyphenol Synthesis Institute, Nanjing 210042, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Wen Chen
3Nanjing Longyuan Natural Polyphenol Synthesis Institute, Nanjing 210042, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Tao
3Nanjing Longyuan Natural Polyphenol Synthesis Institute, Nanjing 210042, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    1

    Total EA concentration of different plants

    Fruits and plantsTotal EAReference
    Bananas2*6,7
    Pear4*6,7
    Tangerine4*6,7
    Pineapples6*6,7
    Plum7*6,7
    Strawberry31-78*6-9
    Pecan nut33* 8
    Walnut59* 8
    Raspberry>150*7,9
    Cloudberry>160*7,9
    Arctic Bramble>160*7,9
    Strawberry cultivar6-34.1** 10
    Pongamia pinnata1.5* (bark) 11
    0.1* (leaves)
    0.4* (seeds)
    Geraniaceae397* 12
    Muscadine grape cultivars587-1900* (skin) 13

    *, mg/100 g dry weight; **, mg/100 g frozen weight.

      • View popup
      2

      Effects of EA in different cancer cell lines or xenografted animals

      Cancer typeCell line/animalEffective concentrationBiological effectsReference
      Breast cancerCell line: MDA-MB-2312.5-20 μMInhibits cancer cell proliferation and migration by downregulating VEGF-induced angiogenesis, VEGF-2 tyrosine kinase activity and its downstream MAPK, and PI3K/Akt pathways 15
      Animal: Female ACI rats400 ppmDownregulates 17β estradiol by reducing 17β-hydroxysteroid dehyrdogenase and reduces mammary tumor incidence 16
      Osteogenic sarcomaCell line: ATCC CRL13434-100 µg/mL (IC50 =6.5 µg/mL)Induces apoptosis by upregulating Bax and activating caspase-3 17
      Pancreatic cancerCell line: MIA PaCa-2, and PANC-110-50 mMStimulates the mitochondrial pathway of apoptosis associated with mitochondrial depolarization, cytochrome C release, and downstream caspase activation 18
      Ovarian carcinomaCell line: ES-2 and PA-110-100 μMElevates p53 and Cip1/p21, decreases cyclin D1 and E levels, and induces caspase-3-mediated apoptosis by increasing the Bax/Bcl-2 ratio 21
      Nasopharyng- eal carcinomaCell line: NPC-BM150-200 μMReduces cancer cell viability by increasing caspase-3 activity, downregulating Bcl-2, and decreasing telomerase activity 22
      LymphomaAnimal: Dalton’s Lymphoma bearing mice40-80 mg/kg body weightPrevents cancer progression and increases life span of DL mice by downregulating the PKC signaling pathway and induces cancer cell death by blocking energy metabolism23,24
      Prostate cancerCell line: PLS10(rat)80-200 μM (IC50 =100 µM)Inhibits invasive potential through action on the activity of proteases, such as collagenase/gelatinase and collagenase IV 37
    PreviousNext
    Back to top

    In this issue

    Cancer Biology and Medicine: 11 (2)
    Cancer Biology & Medicine
    Vol. 11, Issue 2
    1 Jun 2014
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Email Article

    Thank you for your interest in spreading the word on Cancer Biology & Medicine.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Research progress on the anticarcinogenic actions and mechanisms of ellagic acid
    (Your Name) has sent you a message from Cancer Biology & Medicine
    (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
    Citation Tools
    Research progress on the anticarcinogenic actions and mechanisms of ellagic acid
    Hong-Mei Zhang, Lei Zhao, Hao Li, Hao Xu, Wen-Wen Chen, Lin Tao
    Cancer Biology & Medicine Jun 2014, 11 (2) 92-100; DOI: 10.7497/j.issn.2095-3941.2014.02.004

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Research progress on the anticarcinogenic actions and mechanisms of ellagic acid
    Hong-Mei Zhang, Lei Zhao, Hao Li, Hao Xu, Wen-Wen Chen, Lin Tao
    Cancer Biology & Medicine Jun 2014, 11 (2) 92-100; DOI: 10.7497/j.issn.2095-3941.2014.02.004
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Anticarcinogenic effects and mechanisms of EA
      • Other indirect mechanisms involved in EA anticancer actions
      • Current problems and future directions
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • Cytotoxic and Metalloproteinase-inhibitory Effects of Ellagic Acid Against Oral Squamous Cell Carcinoma
    • Google Scholar

    More in this TOC Section

    • Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy
    • Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy
    • From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management
    Show more Review

    Similar Articles

    Keywords

    • Ellagic acid (EA)
    • cancer
    • mechanism

    Navigate

    • Home
    • Current Issue

    More Information

    • About CBM
    • About CACA
    • About TMUCIH
    • Editorial Board
    • Subscription

    For Authors

    • Instructions for authors
    • Journal Policies
    • Submit a Manuscript

    Journal Services

    • Email Alerts
    • Facebook
    • RSS Feeds
    • Twitter

     

    © 2026 Cancer Biology & Medicine

    Powered by HighWire